Show Stocks and Investing Publications • Fri, November 11, 2022
Jonathan Wolleben Maintained (ALT) at Buy with Decreased Target to $26 on, Nov 11th, 2022
eben-maintained-alt-at-buy-with-decreased-target-to-26-on-nov-11th-2022.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIJonathan Wolleben of JMP Securities, Maintained "Altimmune, Inc." (ALT) at Buy with Decreased Target from $28 to $26 on, Nov 11th, 2022.
Jonathan has made no other calls on ALT in the last 4 months.
There are 4 other peers that have a rating on ALT. Out of the 4 peers that are also analyzing ALT, 0 agree with Jonathan's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Jonathan
- Seamus Fernandez of "Guggenheim" Maintained at Strong Buy with Decreased Target to $26 on, Friday, September 16th, 2022
- Roger Song of "Jefferies" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, August 31st, 2022
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $50 on, Wednesday, August 17th, 2022
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $26 on, Friday, August 12th, 2022
Like: 👍